Retail investors account for 51% of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s (SHSE:600196) ownership, while private companies account for 37%

Key Insights

A look at the shareholders of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are retail investors with 51% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

Meanwhile, private companies make up 37% of the company’s shareholders.

Let’s delve deeper into each type of owner of Shanghai Fosun Pharmaceutical (Group), beginning with the chart below.

Check out our latest analysis for Shanghai Fosun Pharmaceutical (Group)

What Does The Institutional Ownership Tell Us About Shanghai Fosun Pharmaceutical (Group)?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

…